Funding for this research was provided by:
Familjen Erling-Perssons Stiftelse
Stockholms Läns Landsting (Alf 20150423, Alf 20170133)
Text and Data Mining valid from 2019-04-16
Received: 26 September 2018
Accepted: 31 March 2019
First Online: 16 April 2019
Ethics approval and consent to participate
: The study was approved by the Ethical Committee on Human Research at Uppsala University Hospital, Uppsala, Sweden.
: Authors declare no conflict of interest.
: WF, HO, and YB are employees and shareholders of Regeneron Pharmaceuticals. JG was an employee and shareholder of Regeneron Pharmaceuticals during the completion of the study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.